- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Neuronetics Inc (STIM)
Neuronetics Inc stock price live, this page displays NASDAQ STIM stock exchange data. View the STIM premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Neuronetics Inc real time stock price chart below.
What Is the Neuronetics Inc Stock Price Today?
The Neuronetics Inc stock price today is 1.325.
What Is the Stock Symbol for Neuronetics Inc?
The stock symbol for Neuronetics Inc is ""STIM.""
What Stock Exchange Does Neuronetics Inc Trade On?
Neuronetics Inc is listed and trades on the NASDAQ stock exchange.
Is Neuronetics Inc a Good Stock to Buy?
Determining whether Neuronetics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the STIM quote. (ISIN: US64131A1051)
What Is the Neuronetics Inc Stock Price Today?
The Neuronetics Inc stock price today is 1.325.
What Is the Stock Symbol for Neuronetics Inc?
The stock symbol for Neuronetics Inc is ""STIM.""
What Stock Exchange Does Neuronetics Inc Trade On?
Neuronetics Inc is listed and trades on the NASDAQ stock exchange.
Is Neuronetics Inc a Good Stock to Buy?
Determining whether Neuronetics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the STIM quote. (ISIN: US64131A1051)
Fair Value
An estimate of a Neuronetics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.320
1.430
52 wk Range
1.001
5.920
STIM is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Neuronetics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.3201.430
52 wk Range
1.0015.920
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
STIM Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Neuronetics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
6.500
Upside
+390.57%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
RSI suggests the stock is in oversold territory
- Form 8K Neuronetics Inc For: 4 November
- Investing.com
- Form 8K Neuronetics Inc For: 4 November
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Neuronetics Inc Company Profile
Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.
Neuronetics Inc SWOT Analysis
Merger Momentum | Neuronetics' merger with Greenbrook TMS shows early success, with significant synergies realized and expanded market presence driving growth potential |
Financial Resilience | Despite high Q1 cash burn, Neuronetics projects cash flow breakeven by Q3 2025 and maintains a healthy current ratio of 2.44 |
Strategic Expansion | SPRAVATO rollout and Brain Music Programming initiatives poised to boost revenue, with potential for adolescent indication coverage opening new markets |
Market Outlook | Analysts set $7.00 price target, reflecting optimism in Neuronetics' growth trajectory amid competitive neurohealth solutions landscape |
Neuronetics Inc Earnings Call Summary for Q2/2025
- Q2 2025 EPS of -$0.15 missed forecast of -$0.08; revenue beat at $38.1M vs $36.59M expected
- Stock fell 12.77% to $4.15 pre-market; gross margin decreased to 46.6% from 74% YoY
- Company targets cash flow positivity by Q4 2025; projects FY revenue of $149M-$155M
- Integration with Greenbrook progressing as anticipated, according to CEO Keith Sullivan
- Q3 guidance: revenue $37M-$39M, gross margin 48-50%, cash flow -$3M to breakeven
Last Updated: 05/08/2025, 16:40
Read Full TranscriptCompare STIM to Peers and Sector
Metrics to compare | STIM | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSTIMPeersSector | |
|---|---|---|---|---|
P/E Ratio | −2.1x | −2.4x | −0.6x | |
PEG Ratio | −0.06 | 0.09 | 0.00 | |
Price/Book | 3.5x | 4.8x | 2.6x | |
Price / LTM Sales | 0.7x | 4.4x | 3.3x | |
Upside (Analyst Target) | 391.2% | 29.1% | 40.1% | |
Fair Value Upside | Unlock | −4.3% | 5.8% | Unlock |
Analyst Ratings
3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 6.500
(+390.57% Upside)
Earnings
Latest Release
Nov 04, 2025
EPS / Forecast
-0.13 / -0.13
Revenue / Forecast
21.80M / 37.85M
People Also Watch
FAQ
What Is the Neuronetics (STIM) Premarket Price Today?
The Neuronetics (STIM) premarket price is 1.390. Premarket price change units: -0.030. Premarket percentage change: -2.110%. Premarket volume: 8,060.000. Current date: 02 Dec 2025. Previous close: 1.420
What Stock Exchange Does Neuronetics Trade On?
Neuronetics is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Neuronetics?
The stock symbol for Neuronetics is "STIM."
What Is the Neuronetics Market Cap?
As of today, Neuronetics market cap is 91.77M.
What Is Neuronetics's Earnings Per Share (TTM)?
The Neuronetics EPS (TTM) is -0.77.
When Is the Next Neuronetics Earnings Date?
Neuronetics will release its next earnings report on 09 Mar 2026.
From a Technical Analysis Perspective, Is STIM a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Neuronetics Stock Split?
Neuronetics has split 0 times.
How Many Employees Does Neuronetics Have?
Neuronetics has 716 employees.
What is the current trading status of Neuronetics (STIM)?
As of 02 Dec 2025, Neuronetics (STIM) is trading at a price of 1.325, with a previous close of 1.420. The stock has fluctuated within a day range of 1.320 to 1.430, while its 52-week range spans from 1.001 to 5.920.
What Is Neuronetics (STIM) Price Target According to Analysts?
The average 12-month price target for Neuronetics is USD6.5, with a high estimate of USD7 and a low estimate of USD5.5. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +390.57% Upside potential.
What Is the STIM Premarket Price?
STIM's last pre-market stock price is 1.390. The pre-market share volume is 8,060.000, and the stock has decreased by -0.030, or -2.110%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.